Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease.
about
High Incidence of Serologic Markers of Inflammatory Bowel Disease in Asymptomatic Patients with Glycogen Storage Disease Type Ia.Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions.Diabetes mellitus in a patient with glycogen storage disease type Ia: a case report.G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a.Progressive development of renal cysts in glycogen storage disease type I.Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context
P2860
Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Lessons from new mouse models ...... an specificity of the disease.
@en
type
label
Lessons from new mouse models ...... an specificity of the disease.
@en
prefLabel
Lessons from new mouse models ...... an specificity of the disease.
@en
P2093
P2860
P1476
Lessons from new mouse models ...... an specificity of the disease.
@en
P2093
Amandine Gautier-Stein
Gilles Mithieux
Julie Clar
P2860
P2888
P304
P356
10.1007/S10545-014-9761-0
P577
2014-08-28T00:00:00Z
P6179
1048392045